RBC Europe’s Allergan plc AGN Stock Holding History

RBC Europe’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-655	Closed	-$116K	–	1101
2020 Q1	$116K	Sell	655 -12	-2%	-$2.26K	0.01%	279
2019 Q4	$128K	Sell	667 -1,615	-71%	-$291K	0.01%	305
2019 Q3	$384K	Buy	2,282 +185	+9%	+$30.1K	0.04%	179
2019 Q2	$351K	Hold	2,097	–	–	0.04%	191
2019 Q1	$307K	Sell	2,097 -168	-7%	-$24.4K	0.03%	199
2018 Q4	$303K	Sell	2,265 -63	-3%	-$10.3K	0.04%	183
2018 Q3	$443K	Hold	2,328	–	–	0.05%	163
2018 Q2	$388K	Buy	2,328 +63	+3%	+$10.1K	0.05%	180
2018 Q1	$381K	Sell	2,265 -60	-3%	-$10.1K	0.05%	177
2017 Q4	$380K	Sell	2,325 -12	-0.5%	-$2.15K	0.05%	182
2017 Q3	$479K	Buy	+2,337	New	+$543K	0.06%	156

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

RBC Europe's AGN Position: Q2 2020 in Review

RBC Europe sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 655 shares — an estimated $116K sold.

RBC Europe first reported a position in AGN in Q3 2017 and held it in 11 quarters. The position peaked at $479K in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

RBC Europe reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
RBC Europe sold 655 Allergan plc shares in Q2 2020, an estimated $116K.
RBC Europe first reported a position in Allergan plc in Q3 2017 and held it in 11 quarters.
RBC Europe's Allergan plc position peaked at $479K in Q3 2017.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.